-
-
-
-
-
-
-
CYTOVIA Inc., IMMUNE Pharma’s Oncology Subsidiary, Announces the Publication of New Results in the British Journal of Haematology and Filing of a World-wide Patent Protecting the Use of Ceplene® in
-
-
-
-
-
-
-
Immune Pharma (IMNP) Subsidiary, Cytovia, Announces Ceplene Licensing & Commercialization Agreement for Latin America
-
-
-
-
-
-
-
Immune Pharma (IMNP): Celator Acquisition Highlights Ceplene's Value in AML
-
-
-
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

